UroGen Pharma discussed real-world experiences and outcomes for ZUSDURI in recurrent bladder cancer during a presentation…
Latest News
Hims & Hers Health Rebounds as GLP-1 Overhang Lifts, 2026 Revenue Target and Eucalyptus Add to Growth Case
Hims & Hers Health has regained market attention after the GLP-1 debate faded, with a 2026…
Joseph Moore Says Dividends Drove Most U.S. Equity Returns Until Michael Jackson’s Thriller Era Changed the Market
Historian and investor Joseph Moore said dividends drove about 90% of U.S. equity returns until a…
LiveRamp Reports 9% Quarterly Revenue Growth as Subscription Retention Improves to 107%
LiveRamp reported fourth-quarter revenue growth of 9% year over year, with annual recurring revenue up 8%…
Prudential to Buy 75% of Bharti Life for ₹3,500 Crore, Trim ICICI Prudential Stake to 10%
Prudential plc plans to acquire a 75% stake in Bharti Life Insurance for ₹3,500 crore while…
Billionaire Warns of a ‘Breathtaking’ Market Correction While Staying Exposed to AI Stocks
A billionaire investor’s warning about a sharp market correction has renewed scrutiny of the crowded AI…
Advanced Energy Industries Gains AI Exposure as Semiconductor and Data Center Demand Lifts Revenue Outlook
Advanced Energy Industries is benefiting from AI-related semiconductor and data center demand, but the investment case…
Western Midstream’s 8% Yield Draws Attention as Throughput Records and EBITDA Growth Support Scale
Western Midstream is drawing attention for an 8% plus yield supported by Q1 throughput records, EBITDA…
Snap Faces Pressure as North American User Declines Undercut Cost-Cut Strategy
Snap is facing renewed scrutiny as North American user declines and a lower-ARPU mix overshadow cost-cutting…
Otis Worldwide Trades Below Its 5-Year Average as Valuation Gap Draws Attention
Otis Worldwide is trading below its five-year average valuation multiple, putting renewed attention on the industrial…